Literature DB >> 26209524

Empirically Derived Trajectories to Dementia Over 15 Years of Follow-up Identified by Using Mixed Membership Models.

Fabrizio Lecci, Brian Junker, Lewis H Kuller, Oscar L Lopez, James T Becker.   

Abstract

Alzheimer disease is the most common form of dementia in the elderly, and the complex relationships among risk factors produce highly variable natural histories from normal cognition through the prodromal stage of mild cognitive impairment (MCI) to clinical dementia. We used a novel statistical approach, mixed membership trajectory models, to capture the variety of such pathways in 652 participants in the Cardiovascular Health Study Cognition Study over 22 years of follow-up (1992-2014). We identified 3 trajectories: a "healthy" profile with a peak probability of MCI between 95 and 100 years of age and only a 50% probability of dementia by age 100; an "intermediate" profile with a peak probability of MCI between 85 and 90 years of age and progression to dementia between 90 and 95 years; and an "unhealthy" profile with a peak probability of progressing to MCI between ages 75 and 80 years and to dementia between the ages of 80 and 85 years. Hypertension, education, race, and the ϵ4 allele of the apolipoprotein E gene all affected the closeness of an individual to 1 or more of the canonical trajectories. These results provide new insights into the natural history of Alzheimer disease and evidence for a potential difference in the pathophysiology of the development of dementia.
© The Author 2015. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  dementia; mild cognitive impairment; mixed membership; trajectory models

Mesh:

Substances:

Year:  2015        PMID: 26209524      PMCID: PMC4528953          DOI: 10.1093/aje/kwv051

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  35 in total

1.  Physical activity predicts gray matter volume in late adulthood: the Cardiovascular Health Study.

Authors:  K I Erickson; C A Raji; O L Lopez; J T Becker; C Rosano; A B Newman; H M Gach; P M Thompson; A J Ho; L H Kuller
Journal:  Neurology       Date:  2010-10-13       Impact factor: 9.910

2.  Voxel Level Survival Analysis of Grey Matter Volume and Incident Mild Cognitive Impairment or Alzheimer's Disease.

Authors:  Lubov E Zeifman; William F Eddy; Oscar L Lopez; Lewis H Kuller; Cyrus Raji; Paul M Thompson; James T Becker
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

3.  DESCRIBING DISABILITY THROUGH INDIVIDUAL-LEVEL MIXTURE MODELS FOR MULTIVARIATE BINARY DATA.

Authors:  Elena A Erosheva; Stephen E Fienberg; Cyrille Joutard
Journal:  Ann Appl Stat       Date:  2007       Impact factor: 2.083

4.  15-year longitudinal study of blood pressure and dementia.

Authors:  I Skoog; B Lernfelt; S Landahl; B Palmertz; L A Andreasson; L Nilsson; G Persson; A Odén; A Svanborg
Journal:  Lancet       Date:  1996-04-27       Impact factor: 79.321

5.  Incidence of dementia in mild cognitive impairment in the cardiovascular health study cognition study.

Authors:  Oscar L Lopez; Lewis H Kuller; James T Becker; Corinne Dulberg; Robert A Sweet; H Michael Gach; Steven T Dekosky
Journal:  Arch Neurol       Date:  2007-03

6.  Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City.

Authors:  M X Tang; G Maestre; W Y Tsai; X H Liu; L Feng; W Y Chung; M Chun; P Schofield; Y Stern; B Tycko; R Mayeux
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

7.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

8.  Incidence and prevalence of dementia in the Cardiovascular Health Study.

Authors:  Annette L Fitzpatrick; Lewis H Kuller; Diane G Ives; Oscar L Lopez; William Jagust; John C S Breitner; Beverly Jones; Constantine Lyketsos; Corinne Dulberg
Journal:  J Am Geriatr Soc       Date:  2004-02       Impact factor: 5.562

9.  Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study.

Authors:  O L Lopez; L H Kuller; P D Mehta; J T Becker; H M Gach; R A Sweet; Y F Chang; R Tracy; S T DeKosky
Journal:  Neurology       Date:  2008-04-09       Impact factor: 9.910

10.  Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia.

Authors:  L J Launer; K Andersen; M E Dewey; L Letenneur; A Ott; L A Amaducci; C Brayne; J R Copeland; J F Dartigues; P Kragh-Sorensen; A Lobo; J M Martinez-Lage; T Stijnen; A Hofman
Journal:  Neurology       Date:  1999-01-01       Impact factor: 9.910

View more
  3 in total

1.  Mixed membership trajectory models of cognitive impairment in the multicenter AIDS cohort study.

Authors:  Samantha A Molsberry; Fabrizio Lecci; Lawrence Kingsley; Brian Junker; Sandra Reynolds; Karl Goodkin; Andrew J Levine; Eileen Martin; Eric N Miller; Cynthia A Munro; Ann Ragin; Ned Sacktor; James T Becker
Journal:  AIDS       Date:  2015-03-27       Impact factor: 4.177

2.  Drivers: A Biologically Contextualized, Cross-Inferential View of the Epidemiology of Neurodegenerative Disorders.

Authors:  Jesús de Pedro-Cuesta; Pablo Martínez-Martín; Alberto Rábano; Enrique Alcalde-Cabero; Fernando José García López; Javier Almazán-Isla; María Ruiz-Tovar; Maria-José Medrano; Fuencisla Avellanal; Olga Calero; Miguel Calero
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 3.  A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers.

Authors:  Emma Lawrence; Carolin Vegvari; Alison Ower; Christoforos Hadjichrysanthou; Frank De Wolf; Roy M Anderson
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.